Wednesday November 25 2009 | Biotechnology feed | All feeds
|
|
Syntarga B.V.
Download detailed PDF Members: Syntarga B.V. is a biopharmaceutical company creating innovative chemistries to link anticancer activity to specificity. The Company develops releasable linker technologies and potent linker-drug combinations for conjugation to tumor-specific targeting units. Syntarga focuses its activities on development of proprietary antibody payload technologies to yield successful Antibody-Drug Conjugate (ADC) products.
This page has been viewed 447 times since April 2007, the link to the organisation's website has been followed 80 times Recent Search Terms used to find this page: syntarga | Syntarga | syntarga nijmegen | antibody drug conjugate syntarga | . Search for more companies in NIJMEGEN This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Syntarga B.V. | |||||||||||||||||||||||||||||||||||||||||||||||||
|